Purchases and Sales Made in Q3 2024 in Longboard Pharmaceuticals, Inc. (LBPH)
This table provides information about the institutional ownership of Longboard Pharmaceuticals, Inc. (LBPH) during Q3 2024. The information is specifically focused on institutions that hold shares of Longboard Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-12.3K- 23.91% |
$340K - $487K
|
39.3K
$2.35M
|
|
Nov 13, 2024
Q3 2024
|
Quantbot Technologies LP
New York, NY |
SELL
|
- |
-16.5K- 90.08% |
$454K - $650K
|
1.81K
$109K
|
|
Nov 13, 2024
Q3 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-33K- 96.12% |
$910K - $1.3M
|
1.33K
$79.9K
|
|
Nov 08, 2024
Q3 2024
|
Jennison Associates LLC
|
SELL
|
- |
-34.4K- 3.62% |
$950K - $1.36M
|
918K
$55M
|
|
Nov 14, 2024
Q3 2024
|
Saturn V Capital Management LLC
Austin, TX |
SELL
|
- |
-39.9K- 55.87% |
$1.1M - $1.58M
|
31.5K
$1.89M
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-46.8K- 61.52% |
$1.29M - $1.85M
|
29.3K
$1.75M
|
|
Nov 14, 2024
Q3 2024
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-50K- 4.55% |
$1.38M - $1.98M
|
1.05M
$63M
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-80.1K- 88.87% |
$2.21M - $3.16M
|
10K
$602K
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-81.2K- 84.26% |
$2.24M - $3.21M
|
15.2K
$909K
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-114K- 67.24% |
$3.15M - $4.51M
|
55.6K
$3.34M
|
|
Nov 14, 2024
Q3 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-189K- 10.62% |
$5.21M - $7.46M
|
1.59M
$95.4M
|
|
Nov 14, 2024
Q3 2024
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-203K- 29.23% |
$5.6M - $8.01M
|
491K
$29.5M
|
|
Nov 14, 2024
Q3 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-252K- 18.59% |
$6.94M - $9.94M
|
1.1M
$66.1M
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-509K- 83.85% |
$14M - $20.1M
|
98K
$5.88M
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-509K- 83.85% |
$14M - $20.1M
|
98K
$5.88M
|